title: A struggle to SURVIVE: to abandon or not to abandon levosimendan?
authors: Javed
authors: J
authors: Butler
authors: Grigorios
authors: G
authors: Giamouzis
authors: Georgios
authors: G
authors: Giannakoulas
mesh_terms: D000208:Acute Disease; D002316:Cardiotonic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004280:Dobutamine / Q000008:administration & dosage / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006835:Hydrazones / Q000008:administration & dosage* / Q000627:therapeutic use; D020097:Natriuretic Peptide, Brain / Q000097:blood / Q000187:drug effects; D011724:Pyridazines / Q000008:administration & dosage* / Q000627:therapeutic use; D000077464:Simendan; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D020097:Natriuretic Peptide, Brain; D000077464:Simendan; D004280:Dobutamine